Presenting glaucoma patients with a minimally invasive approach to lower their IOP with a bleb-forming MIGS procedure can be an appropriate alternative to traditional trabeculectomy or tube surgery.
The Xen gel stent (Allergan) and the not-yet approved PreserFlo microshunt (Santen) can result in improved outcomes and minimized complication profiles for patients early in their disease process, OSN Technology Board Member Carlos Buznego, MD, said.
“We’re able to offer this to patients early in the disease process, but we have to be aware that success rates may not be as high (Read more...)
Uncategorized